Status: current, Defined. Date: 31-Mar 2021. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4528681000168111 | bupivacaine hydrochloride 20 mg / 4 mL intrathecal injection, 5 x 4 mL ampoules (medicinal product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4528691000168114 | bupivacaine hydrochloride 0.5% (20 mg/4 mL) intrathecal injection, 5 x 4 mL ampoules | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| bupivacaine hydrochloride 0.5% (20 mg/4 mL) intrathecal injection, 5 x 4 mL ampoules | Is a | medicinal product pack | true | Inferred relationship | Some | ||
| bupivacaine hydrochloride 0.5% (20 mg/4 mL) intrathecal injection, 5 x 4 mL ampoules | has MPUU | bupivacaine hydrochloride 0.5% (20 mg/4 mL) intrathecal injection, ampoule | true | Inferred relationship | Some | 1466147399 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Marcain Spinal 0.5% (20 mg/4 mL) intrathecal injection, 5 x 4 mL ampoules | Is a | True | bupivacaine hydrochloride 0.5% (20 mg/4 mL) intrathecal injection, 5 x 4 mL ampoules | Inferred relationship | Some |
Reference Sets
Medicinal product pack reference set
FHIR